Niclosamide is an FDA-approved anthelmintic drug for the treatment of parasitic infections.
However, over the past few years, increasing evidence has shown that niclosamide could …

Several valuable biologically active molecules can be obtained through C–H activation
processes. However, the use of expensive and not readily accessible catalysts complicates …

As the pathogenic viruses and the variants of concern greatly threaten human health and
global public safety, the development of convenient and robust strategies enabling rapid …

Human SARS-CoV-2 and avian infectious bronchitis virus (IBV) are highly contagious and
deadly coronaviruses, causing devastating respiratory diseases in humans and chickens …

Abstract The pandemic, COVID-19, has caused social and economic disruption at a larger
pace all over the world. Identification of an effective drug for the deadliest disease is still an …

Repurposing vitamins as antiviral supporting agents is a rapid approach used to control
emerging viral infections. Although there is considerable evidence supporting the use of …

Motivation With the coronavirus pandemic still raging, prophylactic-nasal and early-
treatment throat-sprays could help prevent infection and reduce viral load. Niclosamide has …

The medicinal potential of marine invertebrates' bioactive components that may act as anti-
COVID-19 demonstrated promising results. Ophiocoma dentata, which is common in the …

Herein, a series of new isatin derivatives was designed and synthesized (1–9) as broad-
spectrum antiviral agents. Consequently, the antiviral activities of the synthesized …

The 2019 coronavirus infectious disease (COVID-19) is caused by infection with the new
severe acute respiratory syndrome coronavirus (SARS-CoV-2). Currently, the treatment …